Kiniksa Pharmaceuticals Ltd (KNSA)
US$ 21.36493.91%
Price Chart
Key Statistics
Market Cap
$ 1.5B
P/E Ratio
0.00
Revenue (TTM)
$ 423.24M
Volume
404.62K
52W High
$ 28.15
52W Low
$ 17.38
Dividend Yield
0.00%
Beta
0.31
Technicals
50-Day MA
21.134
200-Day MA
22.5432
52 Week High
28.15
52 Week Low
17.38
About KNSA
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
Employees
315
Headquarters
London, United Kingdom
CEO
Mr. Sanj K. Patel
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg